Author:
Inchauste Lucia,Nurtop Elif,Brisbarre Nadège,Ninove Laetitia,Gallian Pierre,de Lamballerie Xavier,Priet Stéphane
Abstract
AbstractSerosurveys to monitor immunity toward COVID-19 in the population are primarily performed using an ELISA to screen samples for SARS-CoV-2 antibodies, followed by confirmation by a virus neutralization test, which is considered the Gold Standard. However, virus neutralization test may not be feasible for some laboratories because of the requirement for specific facilities and trained personnel. In an attempt to address this limitation, we evaluated three cell-free methods as potential alternatives for assessing SARS-CoV-2 seroprevalence in human population from plasma. We report the establishment of two inhibition ELISAs designed to detect anti-Spike RBD IgG antibodies and a microsphere quantitative suspension array technology assay, based on the Luminex xMAP platform, to measure the presence of antibodies against various SARS-CoV-2 antigens, including anti-RBD. These methods were also compared to a commercial chemiluminescent immunoassay designed for anti-RBD antibodies detection and to the combined ELISA + virus neutralization test strategy. These cell-free assays performed equally to estimate the percentage of positive and negative samples and could be used to determine the prevalence of SARS-CoV-2 antibodies in human population, at least in cohort with high-expected prevalence, without the use of seroneutralization assay.
Funder
Institut de Recherche pour le Développement
Horizon 2020
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733. https://doi.org/10.1056/NEJMoa2001017 (2020).
2. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544.https://doi.org/10.1038/s41564-020-0695-z (2020).
3. de Groot R. J., Baric, R., Enjuanes, L., Gorbalenya, A. E., Holmes, K. V., Perlman, S., Poon, L., Rottier, P. J. M., Talbot, P. J., Woo, P. C. Y. & Ziebuhr, J. Family: Coronaviridae, Virus Taxonomy: 2019 Release. https://talk.ictvonline.org/ictv-reports/ictv_9th_report/positive-sense-rna-viruses-2011/w/posrna_viruses/222/coronaviridae (2019).
4. Corman, V. M., Muth, D., Niemeyer, D. & Drosten, C. Hosts and sources of endemic human coronaviruses. Adv. Virus Res. 100, 163–188. https://doi.org/10.1016/bs.aivir.2018.01.001 (2018).
5. Hamre, D. & Procknow, J. J. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. (New York, N.Y.) 121, 190–193. https://doi.org/10.3181/00379727-121-30734 (1966).